Manoj M Nerurkar

age ~55

from Monmouth Junction, NJ

Get Report
Related to:
Connected to:

Manoj Nerurkar Phones & Addresses

  • 83 Regal Dr, Monmouth Junction, NJ 08852 • 7324385294
  • Monmouth Jct, NJ
  • Edison, NJ
  • Lawrence, KS
  • 12 Mary Ellen Dr, Edison, NJ 08820 • 7324385294

Work

  • Position:
    Protective Service Occupations

Education

  • Degree:
    Associate degree or higher

Resumes

Manoj Nerurkar Photo 1

Manoj Nerurkar

view source

Us Patents

  • Aripiprazole Complex Formulation And Method

    view source
  • US Patent:
    7550445, Jun 23, 2009
  • Filed:
    Jun 14, 2006
  • Appl. No.:
    11/452782
  • Inventors:
    Manoj Nerurkar - Monmouth Junction NJ, US
    Vijay Naringrekar - Princeton NJ, US
  • Assignee:
    Bristol-Myers Squibb Company - Princeton NJ
  • International Classification:
    A61K 31/724
    A61K 31/497
    A61K 31/194
  • US Classification:
    514 58, 51425407, 514574
  • Abstract:
    An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided.

  • Controlled Release Sterile Injectable Aripiprazole Formulation And Method

    view source
  • US Patent:
    7807680, Oct 5, 2010
  • Filed:
    Oct 19, 2004
  • Appl. No.:
    10/968482
  • Inventors:
    Janusz W. Kostanski - Princeton NJ, US
    Takakuni Matsuda - Tokushima, JP
    Manoj Nerurkar - Monmouth Junction NJ, US
    Vijay H. Naringrekar - Princeton NJ, US
  • Assignee:
    Otsuka Pharmaceutical Co., Ltd. - Tokyo
  • International Classification:
    A61K 31/497
  • US Classification:
    51425307, 51425303, 5142521
  • Abstract:
    A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.

  • Controlled Release Sterile Injectable Aripiprazole Formulation And Method

    view source
  • US Patent:
    8030313, Oct 4, 2011
  • Filed:
    Oct 31, 2007
  • Appl. No.:
    11/979149
  • Inventors:
    Janusz W. Kostanski - Princeton NJ, US
    Takakuni Matsuda - Tokushima, JP
    Manoj Nerurkar - Monmouth Junction NJ, US
    Vijay H. Naringrekar - Princeton NJ, US
  • Assignee:
    Otsuka Pharmaceutical Co., Ltd. - Tokyo
  • International Classification:
    A61K 31/497
  • US Classification:
    51425307, 51425303, 5142521
  • Abstract:
    A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.

  • Controlled Release Sterile Injectable Aripiprazole Formulation And Method

    view source
  • US Patent:
    8598178, Dec 3, 2013
  • Filed:
    Oct 31, 2007
  • Appl. No.:
    11/979145
  • Inventors:
    Janusz W. Kostanski - Princeton NJ, US
    Takakuni Matsuda - Tokushima, JP
    Manoj Nerurkar - Monmouth Junction NJ, US
    Vijay H. Naringrekar - Princeton NJ, US
  • Assignee:
    Otsuka Pharmaceutical Co., Ltd. - Tokyo
  • International Classification:
    A61K 31/497
  • US Classification:
    51425307, 51425303, 5142521
  • Abstract:
    A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.

  • Aripiprazole Complex Formulation And Method

    view source
  • US Patent:
    20040077594, Apr 22, 2004
  • Filed:
    Aug 14, 2003
  • Appl. No.:
    10/642366
  • Inventors:
    Manoj Nerurkar - Monmouth Junction NJ, US
    Vijay Naringrekar - Paramus NJ, US
    Mark Dominick - Evansville IN, US
  • International Classification:
    A61K031/724
    C08B037/16
  • US Classification:
    514/058000, 536/046000
  • Abstract:
    An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a -cyclodextrin, preferably, sulfobutyl ether -cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided.

  • Controlled Release Sterile Injectable Aripiprazole Formulation And Method

    view source
  • US Patent:
    20080112985, May 15, 2008
  • Filed:
    Oct 31, 2007
  • Appl. No.:
    11/979144
  • Inventors:
    Janusz Kostanski - Princeton NJ, US
    Takakuni Matsuda - Tokushima, JP
    Manoj Nerurkar - Monmouth Junction NJ, US
    Vijay Naringrekar - Princeton NJ, US
  • International Classification:
    A61K 31/496
    A61K 9/00
  • US Classification:
    424400000, 514253070
  • Abstract:
    A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.

  • Aripiprazole Complex Formulation And Method

    view source
  • US Patent:
    20110160224, Jun 30, 2011
  • Filed:
    Mar 11, 2011
  • Appl. No.:
    13/046124
  • Inventors:
    Manoj NERURKAR - Monmouth Junction NJ, US
    Vijay NARINGREKAR - Princeton NJ, US
  • International Classification:
    A61K 31/497
    A61P 43/00
  • US Classification:
    51425308
  • Abstract:
    An aripiprazole formulation is provided which includes the antipsychotic agent aripiprazole in the form of an inclusion complex in a β-cyclodextrin, preferably, sulfobutyl ether β-cyclodextrin (SBECD), which in the form of an injectable produces reversible generally minimal to mild irritation at the intramuscular injection site. A method for minimizing or reducing irritation caused by aripiprazole at an intramuscular injection site and a method for treating schizophrenia employing the above formulation are also provided.

  • Controlled Release Sterile Injectable Aripiprazole Formulation And Method

    view source
  • US Patent:
    20120100190, Apr 26, 2012
  • Filed:
    Dec 28, 2011
  • Appl. No.:
    13/338827
  • Inventors:
    Janusz W. Kostanski - Princeton NJ, US
    Takakuni Matsuda - Tokushima, JP
    Manoj Nerurkar - Monmouth Junction NJ, US
    Vijay H. Naringrekar - Princeton NJ, US
  • Assignee:
    OTSUKA PHARMACEUTICAL CO., LTD. - Tokyo
  • International Classification:
    A61K 31/496
    A61P 25/18
    A61K 9/14
  • US Classification:
    424400, 51425307
  • Abstract:
    A controlled release sterile freeze-dried aripiprazole formulation is provided which is formed of aripiprazole of a desired mean particle size and a vehicle therefor, which upon constitution with water and intramuscular injection releases aripiprazole over a period of at least about one week and up to about eight weeks. A method for preparing the controlled release freeze-dried aripiprazole formulation, and a method for treating schizophrenia employing the above formulation are also provided.

Facebook

Manoj Nerurkar Photo 2

Manoj Nerurkar

view source

Youtube

BABLA INSTRUMENTAL-GAM DIYE MUSTKIL FILM-SHSH...

BABLA INSTRUMENTAL-GAM DIYE MUSTKIL FILM-SHSHJAJAN...

BABLA INSTRUMENTAL-GAM DIYE MUSTKIL FILM-SHSHJAJAN COLLECTION-YESTE......

  • Category:
    Music
  • Uploaded:
    10 Jul, 2011
  • Duration:
    4m 32s
Get Report for Manoj M Nerurkar from Monmouth Junction, NJ, age ~55
Control profile